Kincell Bio, a leading U.S. cell therapy contract development and manufacturing organization (CDMO), today announced a new ...

Engineering regulatory T cells (Tregs) has emerged as a powerful strategy to achieve durable, antigen-specific immune tolerance for autoimmune and ...

Quell Therapeutics is pressing pause on an engineered regulatory T (Treg) cell therapy for liver transplant patients in order to focus resources on a preclinical autoimmune candidate. | Quell ...

Regeneron Pharmaceuticals already has a presence in immunology, but nothing in its portfolio or pipeline addresses inflammatory bowel disorders nor does the drugmaker have any cell therapies. The ...

A special group of immune cells known as regulatory T cells, or Tregs for short, became an overnight sensation when a trio of U.S. and Japanese scientists won the Nobel Prize in physiology or medicine ...

In a new study, researchers found that a certain protein prevented regulatory T cells (Tregs) from effectively doing their job in controlling the damaging effects of inflammation in a model of ...